4/A
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-20-022234
President and CEO acquired 14,315 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2020-02-08 | Option exercise | +5,515 | 18,020 | D | ||
| Watts Ryan J. President and CEO | 2020-02-08 | Option exercise | +8,800 | 26,820 | D | ||
| Derivatives | |||||||
| Watts Ryan J. President and CEO | 2020-02-08 | Option exercise · Restricted Stock Units | −5,515 | 5,516 | D | ||
| Watts Ryan J. President and CEO | 2020-02-08 | Option exercise · Restricted Stock Units | −8,800 | 26,400 | D | ||
Loading xslF345X03/doc4a.xml…